Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapy

Direct oral anticoagulants (DOACs) are used to prevent and treat thrombosis and thromboembolic events in patients with various diseases. Despite its high efficacy and safety, DOAC therapy is accompanied by increased risk of hemorrhage, including gastrointestinal bleeding. Bleeding risk depends on in...

Popoln opis

Bibliografske podrobnosti

Principais autores:	N. V. Bakulina, S. V. Tikhonov, N. B. Lishchuk, A. B. Karaya
Format:	Artigo
Jezik:	Russo
Izdano:	«FIRMA «SILICEA» LLC 2021-09-01
Serija:	Российский кардиологический журнал
Teme:	anticoagulants direct oral anticoagulants rivaroxoban bleeding gastrointestinal bleeding proton pump inhibitors
Online dostop:	https://russjcardiol.elpub.ru/jour/article/view/4635
Oznake:	Označite Brez oznak, prvi označite!